Publications by authors named "Farnaz Alibabaei"

Article Synopsis
  • * Long-term choline deficiency can lead to various diseases, and supplements may help improve cognitive function, particularly in individuals with neurodegenerative diseases like Alzheimer's.
  • * Research indicates that choline supplementation can enhance memory and brain health by reducing amyloid plaque formation and improving synaptic function, especially when used alongside existing treatments for neurodegenerative diseases.
View Article and Find Full Text PDF

() has emerged as a prominent multidrug-resistant (MDR) pathogen, significantly complicating treatment strategies due to its formidable resistance mechanisms, particularly against carbapenems. Reduced membrane permeability, active antibiotic efflux, and enzymatic hydrolysis via different β-lactamases are the main resistance mechanisms displayed by , and they are all effective against successful treatment approaches. This means that alternate treatment approaches, such as combination therapy that incorporates beta-lactams, β-lactamase inhibitors, and novel antibiotics like cefiderocol, must be investigated immediately.

View Article and Find Full Text PDF
Article Synopsis
  • The review highlights the re-emergence of Mycoplasma pneumoniae, a bacterium linked to atypical pneumonia, particularly in Europe and Asia, driven by factors like climate change and antibiotic resistance.
  • It discusses how the COVID-19 pandemic initially lowered M. pneumoniae cases, but its return suggests changes in transmission dynamics and increased severity due to co-infections with other viruses.
  • The document also emphasizes the need for effective management through surveillance, treatment options like antibiotics and immunomodulators, and lessons learned from COVID-19, such as hygiene practices to mitigate future outbreaks.
View Article and Find Full Text PDF

Cardiovascular disease (CVD) remains the most common cause of death worldwide and has become a public health concern. The proven notable risk factors for CVD are atherosclerosis, hypertension, diabetes, dyslipidemia, inflammation, and some genetic defects. However, research has shown a correlation between metabolic health, gut microbiota, and dietary risk factors.

View Article and Find Full Text PDF